

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.87211341 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.87211341 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.74031175 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.57492647 |
| 5 | cellular response to type I interferon (GO:0071357) | 5.53847712 |
| 6 | type I interferon signaling pathway (GO:0060337) | 5.53847712 |
| 7 | response to type I interferon (GO:0034340) | 5.48184505 |
| 8 | positive regulation of interferon-alpha production (GO:0032727) | 5.25687131 |
| 9 | regulation of interferon-alpha production (GO:0032647) | 4.95767628 |
| 10 | negative regulation of interleukin-12 production (GO:0032695) | 4.72295929 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.64526663 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 4.64526663 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.64526663 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.64526663 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.64526663 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.64526663 |
| 17 | response to interferon-alpha (GO:0035455) | 4.63112898 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.50873078 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.29113932 |
| 20 | response to peptidoglycan (GO:0032494) | 4.26957209 |
| 21 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.22562155 |
| 22 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.22558416 |
| 23 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.19755063 |
| 24 | negative regulation of viral genome replication (GO:0045071) | 4.15007844 |
| 25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.13335166 |
| 26 | cellular response to interferon-beta (GO:0035458) | 4.09064214 |
| 27 | response to interferon-beta (GO:0035456) | 4.06622371 |
| 28 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.04901366 |
| 29 | negative regulation of cell killing (GO:0031342) | 4.04901366 |
| 30 | T-helper 1 type immune response (GO:0042088) | 4.01621828 |
| 31 | regulation of chronic inflammatory response (GO:0002676) | 3.98005476 |
| 32 | positive regulation of antigen processing and presentation (GO:0002579) | 3.97669033 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.97631953 |
| 34 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.96600028 |
| 35 | defense response to protozoan (GO:0042832) | 3.83747785 |
| 36 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.76317960 |
| 37 | positive regulation of interferon-beta production (GO:0032728) | 3.73599940 |
| 38 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.71700059 |
| 39 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.69752517 |
| 40 | regulation of activation of Janus kinase activity (GO:0010533) | 3.64726957 |
| 41 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.64477457 |
| 42 | cellular response to exogenous dsRNA (GO:0071360) | 3.63933002 |
| 43 | cellular response to virus (GO:0098586) | 3.56033994 |
| 44 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.55416881 |
| 45 | response to host immune response (GO:0052572) | 3.55416881 |
| 46 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.53821770 |
| 47 | detection of other organism (GO:0098543) | 3.52648071 |
| 48 | germinal center formation (GO:0002467) | 3.50651467 |
| 49 | regulation of type 2 immune response (GO:0002828) | 3.49202685 |
| 50 | B cell mediated immunity (GO:0019724) | 3.46660019 |
| 51 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.45423649 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 3.43798029 |
| 53 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.43338468 |
| 54 | granulocyte activation (GO:0036230) | 3.42828195 |
| 55 | regulation of antigen processing and presentation (GO:0002577) | 3.41729623 |
| 56 | T cell migration (GO:0072678) | 3.40661447 |
| 57 | respiratory burst (GO:0045730) | 3.39944538 |
| 58 | detection of bacterium (GO:0016045) | 3.39737512 |
| 59 | cellular response to interferon-alpha (GO:0035457) | 3.39161605 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 3.38969332 |
| 61 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.38627671 |
| 62 | natural killer cell mediated immunity (GO:0002228) | 3.38627671 |
| 63 | neutrophil activation (GO:0042119) | 3.37734013 |
| 64 | response to protozoan (GO:0001562) | 3.36224592 |
| 65 | regulation of vitamin metabolic process (GO:0030656) | 3.35863557 |
| 66 | positive regulation of interleukin-12 production (GO:0032735) | 3.33221284 |
| 67 | regulation of gamma-delta T cell activation (GO:0046643) | 3.33208974 |
| 68 | negative regulation of T cell mediated immunity (GO:0002710) | 3.32672260 |
| 69 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.32524650 |
| 70 | * regulation of RIG-I signaling pathway (GO:0039535) | 3.31713198 |
| 71 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.28483916 |
| 72 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.25699564 |
| 73 | negative regulation of interleukin-17 production (GO:0032700) | 3.25123216 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 3.24564760 |
| 75 | positive regulation of type 2 immune response (GO:0002830) | 3.24120191 |
| 76 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.23932910 |
| 77 | cellular response to interferon-gamma (GO:0071346) | 3.21110043 |
| 78 | positive regulation of interleukin-17 production (GO:0032740) | 3.17919735 |
| 79 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.16482741 |
| 80 | positive regulation of defense response to virus by host (GO:0002230) | 3.15817109 |
| 81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.14259605 |
| 82 | response to host (GO:0075136) | 3.14259605 |
| 83 | response to host defenses (GO:0052200) | 3.14259605 |
| 84 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.11042359 |
| 85 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.08198166 |
| 86 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.05926539 |
| 87 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.05877993 |
| 88 | myeloid cell activation involved in immune response (GO:0002275) | 3.05859713 |
| 89 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.05327051 |
| 90 | regulation of T-helper cell differentiation (GO:0045622) | 3.05055458 |
| 91 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.04445388 |
| 92 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.03172636 |
| 93 | lymphocyte chemotaxis (GO:0048247) | 3.02580494 |
| 94 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.02497572 |
| 95 | regulation of podosome assembly (GO:0071801) | 3.01961602 |
| 96 | myeloid dendritic cell differentiation (GO:0043011) | 3.01887059 |
| 97 | regulation of interleukin-17 production (GO:0032660) | 3.01537686 |
| 98 | response to interferon-gamma (GO:0034341) | 3.01119263 |
| 99 | regulation of defense response to virus by host (GO:0050691) | 3.00712450 |
| 100 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.00283510 |
| 101 | * defense response to virus (GO:0051607) | 3.00076414 |
| 102 | myeloid dendritic cell activation (GO:0001773) | 2.99050101 |
| 103 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.98115797 |
| 104 | negative regulation of type 2 immune response (GO:0002829) | 2.97454315 |
| 105 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.96653417 |
| 106 | detection of external biotic stimulus (GO:0098581) | 2.94496994 |
| 107 | response to muramyl dipeptide (GO:0032495) | 2.94042483 |
| 108 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.93698811 |
| 109 | interferon-gamma secretion (GO:0072643) | 2.92728410 |
| 110 | dendritic cell differentiation (GO:0097028) | 2.92331056 |
| 111 | positive regulation of humoral immune response (GO:0002922) | 2.91608590 |
| 112 | regulation of tolerance induction (GO:0002643) | 2.91543098 |
| 113 | superoxide anion generation (GO:0042554) | 2.90765369 |
| 114 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.90303806 |
| 115 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90290018 |
| 116 | positive regulation of heat generation (GO:0031652) | 2.90086941 |
| 117 | detection of molecule of bacterial origin (GO:0032490) | 2.89904962 |
| 118 | positive regulation of B cell differentiation (GO:0045579) | 2.88311179 |
| 119 | regulation of chemokine biosynthetic process (GO:0045073) | 2.88262447 |
| 120 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.88053852 |
| 121 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.87154024 |
| 122 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.86611631 |
| 123 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.86363547 |
| 124 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.83733265 |
| 125 | regulation of interferon-beta production (GO:0032648) | 2.83696177 |
| 126 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.83319390 |
| 127 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.82974824 |
| 128 | negative regulation of viral process (GO:0048525) | 2.82554958 |
| 129 | cellular response to zinc ion (GO:0071294) | 2.82126529 |
| 130 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.80697549 |
| 131 | regulation of T-helper 1 type immune response (GO:0002825) | 2.80441648 |
| 132 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.80259155 |
| 133 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.80105285 |
| 134 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80098039 |
| 135 | regulation of viral genome replication (GO:0045069) | 2.78450127 |
| 136 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.77355646 |
| 137 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.76961528 |
| 138 | regulation of B cell differentiation (GO:0045577) | 2.76318389 |
| 139 | regulation of interleukin-12 production (GO:0032655) | 2.75279834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.07528121 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.63340458 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.87134511 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.47474709 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.26094346 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.24252612 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.99420808 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.37955752 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31587436 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22157845 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.05261306 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.01517511 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92458947 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.81603040 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.63259346 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.59742679 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.45344287 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.19224034 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18506623 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.09950167 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 1.98243583 |
| 22 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.95972699 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95425508 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90153907 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.87500810 |
| 26 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86430828 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.85972813 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83313654 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78429649 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.78258650 |
| 31 | * MYB_26560356_Chip-Seq_TH1_Human | 1.74391986 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71140326 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70427968 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.67744347 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66204862 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64145137 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61019674 |
| 38 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.55582412 |
| 39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54697010 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54354119 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54055492 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52068196 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48743437 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42685737 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.42064673 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37779740 |
| 47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37572729 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36999423 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32956503 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.32388459 |
| 51 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31383291 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27256389 |
| 53 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26198825 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25303202 |
| 55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24760259 |
| 56 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23747086 |
| 57 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21468567 |
| 58 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17051436 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16061204 |
| 60 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15787757 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15474641 |
| 62 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15156186 |
| 63 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.14851499 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14439004 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.12948498 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12725649 |
| 67 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10734554 |
| 68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08021263 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07845986 |
| 70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07755572 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06806358 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06288984 |
| 73 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05333876 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03085054 |
| 75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02535836 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01649771 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01117341 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.00934594 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97418127 |
| 80 | MAF_26560356_Chip-Seq_TH2_Human | 0.96032148 |
| 81 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94947655 |
| 82 | MYC_22102868_ChIP-Seq_BL_Human | 0.94784068 |
| 83 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94413127 |
| 84 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93878757 |
| 85 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93665948 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92731634 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90568034 |
| 88 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.90471805 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88723583 |
| 90 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87357424 |
| 91 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86961488 |
| 92 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86446043 |
| 93 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85528515 |
| 94 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.84602789 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84564964 |
| 96 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.83512756 |
| 97 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.82784817 |
| 98 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.81445931 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81339495 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80376188 |
| 101 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77311130 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76816098 |
| 103 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.76789134 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76677196 |
| 105 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.75666601 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.75238310 |
| 107 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70670449 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70050099 |
| 109 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.69881689 |
| 110 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.68141871 |
| 111 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.65387371 |
| 112 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.64005897 |
| 113 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.63922721 |
| 114 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62106631 |
| 115 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.61635483 |
| 116 | P300_27268052_Chip-Seq_Bcells_Human | 0.59775234 |
| 117 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.59592669 |
| 118 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.59100288 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.57663956 |
| 120 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.55001202 |
| 121 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.54669637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.11688211 |
| 2 | * MP0009785_altered_susceptibility_to | 4.17631214 |
| 3 | MP0003436_decreased_susceptibility_to | 3.44418862 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.42925647 |
| 5 | MP0000685_abnormal_immune_system | 3.42383033 |
| 6 | MP0005671_abnormal_response_to | 3.29704055 |
| 7 | MP0001790_abnormal_immune_system | 3.27097534 |
| 8 | MP0005387_immune_system_phenotype | 3.27097534 |
| 9 | MP0006082_CNS_inflammation | 3.17739370 |
| 10 | MP0003724_increased_susceptibility_to | 3.16058092 |
| 11 | * MP0005025_abnormal_response_to | 3.15028661 |
| 12 | MP0005000_abnormal_immune_tolerance | 3.08873782 |
| 13 | MP0002419_abnormal_innate_immunity | 2.91015278 |
| 14 | MP0001800_abnormal_humoral_immune | 2.79260991 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.68804943 |
| 16 | * MP0002723_abnormal_immune_serum | 2.67043285 |
| 17 | MP0001819_abnormal_immune_cell | 2.37687740 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.34050555 |
| 19 | MP0004510_myositis | 2.21361334 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.12410824 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.11388561 |
| 22 | MP0003303_peritoneal_inflammation | 2.10818817 |
| 23 | MP0005451_abnormal_body_composition | 2.05354291 |
| 24 | MP0001845_abnormal_inflammatory_respons | 1.94010370 |
| 25 | MP0004947_skin_inflammation | 1.93455463 |
| 26 | * MP0008469_abnormal_protein_level | 1.90107764 |
| 27 | MP0001853_heart_inflammation | 1.88066952 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.86265713 |
| 29 | MP0002398_abnormal_bone_marrow | 1.85840364 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.85184666 |
| 31 | MP0002405_respiratory_system_inflammati | 1.84845105 |
| 32 | MP0000716_abnormal_immune_system | 1.83838266 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.82940567 |
| 34 | MP0002006_tumorigenesis | 1.80183715 |
| 35 | * MP0009764_decreased_sensitivity_to | 1.79665518 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.73825740 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.65650636 |
| 38 | MP0008004_abnormal_stomach_pH | 1.65571152 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.61723106 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.52556747 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.51582363 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.51582363 |
| 43 | MP0002429_abnormal_blood_cell | 1.50770436 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.49289187 |
| 45 | MP0002332_abnormal_exercise_endurance | 1.46167762 |
| 46 | MP0009840_abnormal_foam_cell | 1.44806415 |
| 47 | MP0002722_abnormal_immune_system | 1.40653467 |
| 48 | MP0000343_altered_response_to | 1.38205852 |
| 49 | MP0003448_altered_tumor_morphology | 1.36463793 |
| 50 | MP0005310_abnormal_salivary_gland | 1.36223483 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.31435107 |
| 52 | MP0004782_abnormal_surfactant_physiolog | 1.27302355 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.26551178 |
| 54 | MP0009278_abnormal_bone_marrow | 1.26370972 |
| 55 | MP0003075_altered_response_to | 1.21884046 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.19351892 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.18340712 |
| 58 | MP0000858_altered_metastatic_potential | 1.16381290 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.16106870 |
| 60 | * MP0009763_increased_sensitivity_to | 1.12685149 |
| 61 | MP0006054_spinal_hemorrhage | 1.10558669 |
| 62 | MP0001873_stomach_inflammation | 1.08650208 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.01308594 |
| 64 | MP0003195_calcinosis | 1.00977958 |
| 65 | MP0002933_joint_inflammation | 1.00595121 |
| 66 | MP0008260_abnormal_autophagy | 0.97614068 |
| 67 | MP0003091_abnormal_cell_migration | 0.95963422 |
| 68 | MP0004883_abnormal_blood_vessel | 0.92582824 |
| 69 | MP0003866_abnormal_defecation | 0.91096724 |
| 70 | MP0000703_abnormal_thymus_morphology | 0.89579367 |
| 71 | MP0003186_abnormal_redox_activity | 0.88663687 |
| 72 | MP0005174_abnormal_tail_pigmentation | 0.87997779 |
| 73 | MP0005166_decreased_susceptibility_to | 0.87983573 |
| 74 | MP0005390_skeleton_phenotype | 0.87582883 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 0.87406858 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.85847790 |
| 77 | MP0010307_abnormal_tumor_latency | 0.84414387 |
| 78 | MP0000490_abnormal_crypts_of | 0.84353418 |
| 79 | MP0005083_abnormal_biliary_tract | 0.84002687 |
| 80 | MP0001663_abnormal_digestive_system | 0.83103680 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.80419413 |
| 82 | MP0001542_abnormal_bone_strength | 0.79454336 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.79045030 |
| 84 | MP0001851_eye_inflammation | 0.78554155 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.78181095 |
| 86 | MP0000604_amyloidosis | 0.75527108 |
| 87 | MP0005165_increased_susceptibility_to | 0.73977928 |
| 88 | MP0008874_decreased_physiological_sensi | 0.73268296 |
| 89 | MP0002254_reproductive_system_inflammat | 0.71530314 |
| 90 | MP0000609_abnormal_liver_physiology | 0.68894722 |
| 91 | MP0005360_urolithiasis | 0.68713100 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.68682888 |
| 93 | MP0003690_abnormal_glial_cell | 0.68042762 |
| 94 | MP0000249_abnormal_blood_vessel | 0.67634668 |
| 95 | MP0001501_abnormal_sleep_pattern | 0.67203996 |
| 96 | MP0001348_abnormal_lacrimal_gland | 0.66078834 |
| 97 | MP0005023_abnormal_wound_healing | 0.65930660 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.65676718 |
| 99 | MP0005164_abnormal_response_to | 0.65377599 |
| 100 | MP0005535_abnormal_body_temperature | 0.65250220 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 0.65094666 |
| 102 | MP0000920_abnormal_myelination | 0.62978639 |
| 103 | MP0002139_abnormal_hepatobiliary_system | 0.61570093 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.61127505 |
| 105 | MP0000015_abnormal_ear_pigmentation | 0.58397493 |
| 106 | MP0003045_fibrosis | 0.58073145 |
| 107 | MP0003656_abnormal_erythrocyte_physiolo | 0.57890020 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.57415307 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.57181808 |
| 110 | MP0003828_pulmonary_edema | 0.56876657 |
| 111 | MP0000598_abnormal_liver_morphology | 0.55036861 |
| 112 | MP0003566_abnormal_cell_adhesion | 0.54831549 |
| 113 | MP0002019_abnormal_tumor_incidence | 0.54681887 |
| 114 | MP0003795_abnormal_bone_structure | 0.54175469 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.53877196 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.53849949 |
| 117 | MP0000371_diluted_coat_color | 0.53041391 |
| 118 | MP0001764_abnormal_homeostasis | 0.52609473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.03943777 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.82182143 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.79317697 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.11811897 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.92464543 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 4.79349765 |
| 7 | Chronic otitis media (HP:0000389) | 4.78192504 |
| 8 | Myositis (HP:0100614) | 4.68200063 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.65677145 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.09472451 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.06180268 |
| 12 | Orchitis (HP:0100796) | 4.04856589 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.99098952 |
| 14 | Recurrent skin infections (HP:0001581) | 3.91911775 |
| 15 | Increased IgM level (HP:0003496) | 3.89691866 |
| 16 | Recurrent viral infections (HP:0004429) | 3.89524597 |
| 17 | Vasculitis (HP:0002633) | 3.87335908 |
| 18 | Nasal polyposis (HP:0100582) | 3.67357329 |
| 19 | Optic neuritis (HP:0100653) | 3.65861930 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.65861930 |
| 21 | Basal ganglia calcification (HP:0002135) | 3.65602211 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.65124078 |
| 23 | Recurrent bronchitis (HP:0002837) | 3.38403995 |
| 24 | Abnormality of the nasal mucosa (HP:0000433) | 3.33551857 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.30661847 |
| 26 | Gingivitis (HP:0000230) | 3.29042602 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 3.28174885 |
| 28 | Hypergammaglobulinemia (HP:0010702) | 3.22398030 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 3.20656299 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.16521328 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.16521328 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 3.09606225 |
| 33 | Periodontitis (HP:0000704) | 2.99583159 |
| 34 | Stomatitis (HP:0010280) | 2.99206113 |
| 35 | Obstructive lung disease (HP:0006536) | 2.99136377 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99136377 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.96386019 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.94415697 |
| 39 | Gingival bleeding (HP:0000225) | 2.92022956 |
| 40 | Meningitis (HP:0001287) | 2.90856574 |
| 41 | Pustule (HP:0200039) | 2.88317988 |
| 42 | Disinhibition (HP:0000734) | 2.87506282 |
| 43 | Pulmonary infiltrates (HP:0002113) | 2.86844468 |
| 44 | Cellulitis (HP:0100658) | 2.83808946 |
| 45 | Loss of speech (HP:0002371) | 2.74703421 |
| 46 | Abnormality of T cell physiology (HP:0011840) | 2.73516355 |
| 47 | Petechiae (HP:0000967) | 2.69954561 |
| 48 | Arterial thrombosis (HP:0004420) | 2.69550944 |
| 49 | Chronic sinusitis (HP:0011109) | 2.68705470 |
| 50 | Hemoptysis (HP:0002105) | 2.62013187 |
| 51 | Abnormality of T cells (HP:0002843) | 2.60525685 |
| 52 | Autoimmune hemolytic anemia (HP:0001890) | 2.59497289 |
| 53 | Thrombocytosis (HP:0001894) | 2.58554796 |
| 54 | Abnormality of T cell number (HP:0011839) | 2.58538024 |
| 55 | Increased serum ferritin (HP:0003281) | 2.57427091 |
| 56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.55003295 |
| 57 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.55003295 |
| 58 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.55003295 |
| 59 | Leukocytosis (HP:0001974) | 2.52522831 |
| 60 | Tetraparesis (HP:0002273) | 2.52499650 |
| 61 | Amyloidosis (HP:0011034) | 2.46592268 |
| 62 | Abnormality of the pleura (HP:0002103) | 2.46147364 |
| 63 | Eosinophilia (HP:0001880) | 2.45336287 |
| 64 | Pulmonary embolism (HP:0002204) | 2.44939855 |
| 65 | Epistaxis (HP:0000421) | 2.44203878 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.43795849 |
| 67 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42684045 |
| 68 | Mucopolysacchariduria (HP:0008155) | 2.42684045 |
| 69 | Joint swelling (HP:0001386) | 2.41848792 |
| 70 | Panhypogammaglobulinemia (HP:0003139) | 2.41631250 |
| 71 | Urticaria (HP:0001025) | 2.39763656 |
| 72 | Joint hemorrhage (HP:0005261) | 2.37862037 |
| 73 | Purpura (HP:0000979) | 2.35984906 |
| 74 | Mutism (HP:0002300) | 2.34760402 |
| 75 | T lymphocytopenia (HP:0005403) | 2.33926200 |
| 76 | Prostate neoplasm (HP:0100787) | 2.33478831 |
| 77 | Keratoconjunctivitis sicca (HP:0001097) | 2.32097524 |
| 78 | Polyneuropathy (HP:0001271) | 2.31839380 |
| 79 | Hematochezia (HP:0002573) | 2.29430788 |
| 80 | Osteomyelitis (HP:0002754) | 2.29297289 |
| 81 | Anorexia (HP:0002039) | 2.28914238 |
| 82 | Recurrent lower respiratory tract infections (HP:0002783) | 2.28798367 |
| 83 | IgG deficiency (HP:0004315) | 2.28456344 |
| 84 | Nuclear cataract (HP:0100018) | 2.27532494 |
| 85 | IgM deficiency (HP:0002850) | 2.26432173 |
| 86 | Increased IgE level (HP:0003212) | 2.24508264 |
| 87 | Abnormality of the pericardium (HP:0001697) | 2.23571308 |
| 88 | Prolonged bleeding time (HP:0003010) | 2.22840860 |
| 89 | Chronic diarrhea (HP:0002028) | 2.21912479 |
| 90 | Colitis (HP:0002583) | 2.21833351 |
| 91 | Parakeratosis (HP:0001036) | 2.21369708 |
| 92 | Abnormality of the prostate (HP:0008775) | 2.21355269 |
| 93 | Episodic fever (HP:0001954) | 2.21109999 |
| 94 | Inflammation of the large intestine (HP:0002037) | 2.20867325 |
| 95 | Spontaneous hematomas (HP:0007420) | 2.19746782 |
| 96 | Acne (HP:0001061) | 2.17830751 |
| 97 | Agammaglobulinemia (HP:0004432) | 2.17532763 |
| 98 | Keratoconjunctivitis (HP:0001096) | 2.16986337 |
| 99 | Progressive neurologic deterioration (HP:0002344) | 2.16429542 |
| 100 | Myocardial infarction (HP:0001658) | 2.16102820 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 2.16010999 |
| 102 | Thyroiditis (HP:0100646) | 2.14299799 |
| 103 | Vertigo (HP:0002321) | 2.12635066 |
| 104 | Gastrointestinal inflammation (HP:0004386) | 2.11234009 |
| 105 | Granulocytopenia (HP:0001913) | 2.10812988 |
| 106 | Poor head control (HP:0002421) | 2.10360565 |
| 107 | Glomerulopathy (HP:0100820) | 2.09946658 |
| 108 | Hepatosplenomegaly (HP:0001433) | 2.09769103 |
| 109 | Abnormality of eosinophils (HP:0001879) | 2.09628278 |
| 110 | Complement deficiency (HP:0004431) | 2.09098447 |
| 111 | Encephalitis (HP:0002383) | 2.08931856 |
| 112 | Gangrene (HP:0100758) | 2.08136798 |
| 113 | Abnormality of the endocardium (HP:0004306) | 2.05749342 |
| 114 | Malnutrition (HP:0004395) | 2.05669439 |
| 115 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05099040 |
| 116 | Chest pain (HP:0100749) | 2.04737617 |
| 117 | Neurofibrillary tangles (HP:0002185) | 2.04570154 |
| 118 | Glomerulonephritis (HP:0000099) | 2.04272711 |
| 119 | Lymphopenia (HP:0001888) | 2.03807080 |
| 120 | Arthralgia (HP:0002829) | 2.03168150 |
| 121 | Skin ulcer (HP:0200042) | 2.03058380 |
| 122 | Gastrointestinal stroma tumor (HP:0100723) | 2.03039573 |
| 123 | Thick nail (HP:0001805) | 2.03023631 |
| 124 | Dysostosis multiplex (HP:0000943) | 2.01560788 |
| 125 | Porencephaly (HP:0002132) | 2.01316528 |
| 126 | Abnormality of glycolipid metabolism (HP:0010969) | 1.99910167 |
| 127 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.99910167 |
| 128 | Memory impairment (HP:0002354) | 1.98236251 |
| 129 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.96942687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.27067588 |
| 2 | TYK2 | 4.01645056 |
| 3 | TBK1 | 3.58604005 |
| 4 | MAP4K1 | 3.53230741 |
| 5 | IRAK4 | 3.46955633 |
| 6 | KIT | 3.29001285 |
| 7 | IKBKE | 3.25166065 |
| 8 | JAK3 | 3.14076495 |
| 9 | IRAK3 | 3.09281050 |
| 10 | BLK | 3.06707427 |
| 11 | PRPF4B | 2.73470436 |
| 12 | ERN1 | 2.59636717 |
| 13 | JAK1 | 2.51812563 |
| 14 | TXK | 2.51509792 |
| 15 | IKBKB | 2.25074004 |
| 16 | TAOK2 | 2.20526384 |
| 17 | RIPK4 | 2.14930246 |
| 18 | FGFR4 | 2.09406677 |
| 19 | ZAP70 | 1.82412991 |
| 20 | CSF1R | 1.81346181 |
| 21 | SYK | 1.76320374 |
| 22 | BTK | 1.74368142 |
| 23 | TAOK1 | 1.73455428 |
| 24 | TEC | 1.71080720 |
| 25 | FLT3 | 1.70795281 |
| 26 | PIM2 | 1.58823466 |
| 27 | DDR2 | 1.56396771 |
| 28 | PBK | 1.56176954 |
| 29 | MAP3K13 | 1.55067042 |
| 30 | CSK | 1.44956490 |
| 31 | TAOK3 | 1.40075243 |
| 32 | IRAK1 | 1.38223184 |
| 33 | CHUK | 1.34602393 |
| 34 | NME2 | 1.33822269 |
| 35 | MOS | 1.32643679 |
| 36 | HCK | 1.32430314 |
| 37 | CDC42BPA | 1.31498524 |
| 38 | LCK | 1.25543275 |
| 39 | FGFR3 | 1.24134031 |
| 40 | LYN | 1.20457193 |
| 41 | ADRBK2 | 1.20132139 |
| 42 | EPHA3 | 1.16507458 |
| 43 | FES | 1.14662758 |
| 44 | EPHB1 | 1.12804205 |
| 45 | NEK9 | 1.10456179 |
| 46 | ITK | 1.10202259 |
| 47 | MAP3K1 | 1.04440915 |
| 48 | RPS6KA4 | 1.01679632 |
| 49 | JAK2 | 1.01615584 |
| 50 | TRIB3 | 1.00959182 |
| 51 | MATK | 0.97902071 |
| 52 | MAP3K3 | 0.95258732 |
| 53 | PIM1 | 0.93304612 |
| 54 | EIF2AK2 | 0.92556022 |
| 55 | HIPK2 | 0.86937456 |
| 56 | IRAK2 | 0.83678364 |
| 57 | STK10 | 0.81794583 |
| 58 | TGFBR2 | 0.81296587 |
| 59 | NLK | 0.78042248 |
| 60 | MAP2K3 | 0.76608421 |
| 61 | TRPM7 | 0.75830127 |
| 62 | TESK2 | 0.75092313 |
| 63 | STK4 | 0.73144152 |
| 64 | MST4 | 0.69285741 |
| 65 | SIK1 | 0.68761931 |
| 66 | BMPR2 | 0.64752488 |
| 67 | MAPK7 | 0.61133191 |
| 68 | BMX | 0.59742402 |
| 69 | LRRK2 | 0.58957753 |
| 70 | PRKCD | 0.55932085 |
| 71 | SIK3 | 0.53756749 |
| 72 | PRKCQ | 0.52160433 |
| 73 | ABL2 | 0.51744531 |
| 74 | ABL1 | 0.51505259 |
| 75 | YES1 | 0.51364207 |
| 76 | MARK2 | 0.49802011 |
| 77 | GRK6 | 0.49139048 |
| 78 | KDR | 0.48693317 |
| 79 | TYRO3 | 0.48045468 |
| 80 | PDPK1 | 0.47030617 |
| 81 | MAP3K5 | 0.44648515 |
| 82 | MAPK11 | 0.44558073 |
| 83 | PRKD2 | 0.43667330 |
| 84 | FGR | 0.43375082 |
| 85 | PTK6 | 0.42056219 |
| 86 | MARK3 | 0.41947366 |
| 87 | EGFR | 0.39111859 |
| 88 | CLK1 | 0.37739168 |
| 89 | PIK3CG | 0.36992780 |
| 90 | PKN2 | 0.36906714 |
| 91 | SMG1 | 0.35916726 |
| 92 | CAMKK2 | 0.35482668 |
| 93 | FYN | 0.34113262 |
| 94 | ICK | 0.33581652 |
| 95 | RPS6KA6 | 0.33103950 |
| 96 | IGF1R | 0.31240473 |
| 97 | MAPKAPK2 | 0.30973969 |
| 98 | DYRK1B | 0.30659151 |
| 99 | MAP3K10 | 0.30442150 |
| 100 | PKN1 | 0.30426056 |
| 101 | KSR2 | 0.28517611 |
| 102 | DAPK2 | 0.26463577 |
| 103 | MAPK4 | 0.25893338 |
| 104 | PRKG2 | 0.25808854 |
| 105 | RPS6KA5 | 0.24673595 |
| 106 | EIF2AK3 | 0.24022426 |
| 107 | TESK1 | 0.23953033 |
| 108 | TGFBR1 | 0.23412146 |
| 109 | MAP3K11 | 0.23328090 |
| 110 | MAP2K6 | 0.22818932 |
| 111 | PDK1 | 0.22636133 |
| 112 | CDK4 | 0.22338523 |
| 113 | ATR | 0.22076401 |
| 114 | ARAF | 0.22022661 |
| 115 | MAPK3 | 0.21861234 |
| 116 | GRK7 | 0.21021607 |
| 117 | STK3 | 0.20766888 |
| 118 | TNK2 | 0.20184260 |
| 119 | RIPK1 | 0.19470388 |
| 120 | RPS6KC1 | 0.18787532 |
| 121 | RPS6KL1 | 0.18787532 |
| 122 | ERBB3 | 0.18246941 |
| 123 | SIK2 | 0.17091169 |
| 124 | MST1R | 0.16908808 |
| 125 | CDK6 | 0.16546457 |
| 126 | RPS6KA1 | 0.15945508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.44610376 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.28298174 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.16311141 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.14498640 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.85441200 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.83380978 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.80799958 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.72991712 |
| 9 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.72269731 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.66922135 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.28509397 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.27634808 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24245348 |
| 14 | Influenza A_Homo sapiens_hsa05164 | 2.20057799 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.15980019 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.15319679 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 2.13552842 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.08207331 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.07852091 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.95555616 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.95451663 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82089845 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.73151270 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.67375089 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.64470142 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.61741806 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61629932 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57945211 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.57546615 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54622830 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.51870370 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.47235508 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.43208166 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37766778 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27752302 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.24488627 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.23494000 |
| 38 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.20331535 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.19198803 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.18734584 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18039748 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17515039 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.11850802 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11537388 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04917809 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.00190969 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 0.99040754 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.94428073 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93865513 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86666530 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.82683816 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.71731049 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70486346 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.68561952 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67202384 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66585360 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64348992 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62320851 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62051510 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61718957 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.57603402 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57245807 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56580692 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56249530 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54752711 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.52542467 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51648333 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50320967 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49082167 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48962377 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47283044 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46885003 |
| 73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46574790 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46078700 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44916143 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.44003687 |
| 77 | Base excision repair_Homo sapiens_hsa03410 | 0.42082382 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40911782 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40619119 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.40233913 |
| 81 | Proteasome_Homo sapiens_hsa03050 | 0.36026828 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35237914 |
| 83 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34734179 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33270593 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.31862584 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31272607 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30258422 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30034925 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29807274 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25674870 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.25380688 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24878668 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24206518 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23203652 |
| 95 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.22920579 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.22367961 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22343871 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.22120082 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22050310 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.22011673 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21899935 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.21692490 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.21516849 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20129292 |
| 105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.19049015 |
| 106 | Histidine metabolism_Homo sapiens_hsa00340 | 0.18347733 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16464632 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.16123422 |
| 109 | DNA replication_Homo sapiens_hsa03030 | 0.15359383 |
| 110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.14076048 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.13938111 |
| 112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.12516325 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.11534215 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10743896 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10460264 |
| 116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.09788450 |
| 117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.09733435 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.09720354 |
| 119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.09681891 |
| 120 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.09588701 |
| 121 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.08913506 |

